The Digital Medicine Society (DiMe) announced it is partnering with Alcohol and Drug Services (ADS), Duke University, Google Fitbit, Morse Clinics, North Carolina Central University, Ōura, ProofPilot, Triangle CERSI and the University of North…
Continue Reading
The U.S. Drug Enforcement Administration has proposed draft guidance to establish a framework for prescribing controlled substances via telemedicine.The proposal introduces three types of special registrations. Telemedicine prescribing registration allows qualified practitioners to prescribe…
Continue Reading
After launching a collaboration in 2023 to provide virtual opioid use disorder support to those transitioning out of prisons, Bicycle Health, Wellpath and the Federal Bureau of Prisons (FBOP) have signed an additional one-year…
Continue Reading
The Growing Opioid Crisis During COVID-19
The United States faced an intensifying drug crisis during the COVID-19 pandemic, with opioid-related deaths surging dramatically. Drug overdose fatalities increased from 91,799 in 2020 to 107,941 in 2022,…
Welcome to the January edition of Digital Health Digest, your trusted source for the latest in digital health and healthcare technology!In this episode, we cover major updates transforming the digital health landscape—from Bicycle Health…
Continue Reading
Bicycle Health, a company that offers virtual opioid disorder treatment, announced it secured $16.5 million in funding.Existing Questa Capital led the round with participation from other existing investors, including Frist Cressey Ventures, SignalFire, Hustle…
Continue Reading
What You Should Know:
– Bicycle Health, the nation’s largest provider of virtual opioid use disorder (OUD) treatment, today announced a $16.5 million funding round led by Questa Capital, with participation from all existing and…
Continue Reading
Machine learning has increasingly been applied to predict opioid-related harms due to its ability to handle complex interactions and generating actionable predictions. This review evaluated the types and quality of ML methods in opioid…
Continue Reading
Introduction
PursueCare, a leader in virtual addiction treatment, has relaunched RESET and RESET-O, two FDA-cleared prescription digital therapeutics (PDTs), designed to help individuals struggling with substance use disorder (SUD) and opioid use disorder (OUD). Originally…
PursueCare, a company that provides personalized virtual addiction treatment, announced the re-release of FDA-cleared RESET and RESET-O, prescription digital therapeutics for substance use disorder and opioid use disorder.RESET and RESET-O were initially developed and…
Continue Reading
